Y. Wan

Urinary levels of RANTES and M-CSF are predictors of lupus nephritis flare

L. Wang, D. Liu, J. Li, 2007, Inflammation Research.

The efficacy and safety of the combination of axitinib and pembrolizumab-activated autologous DC-CIK cell immunotherapy for patients with advanced renal cell carcinoma: a phase 2 study

Yan Ding, Jing-jing Zhao, Qi-jing Wang, 2021 .

The efficacy and safety of the combination of axitinib and pembrolizumab‐activated autologous DC‐CIK cell immunotherapy for patients with advanced renal cell carcinoma: a phase 2 study

F. Zhou, J. Xia, P. Dong, 2021, Clinical & translational immunology.

Severe delayed pulmonary toxicity following PD‐L1–specific CAR‐T cell therapy for non‐small cell lung cancer

J. Xia, Li Zhang, W. Fang, 2020, Clinical & translational immunology.